Abstract:Purpose Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the most frequently mutated human tumor suppressor genes. The present study aims to investigate the role of PTEN mutation in breast carcinogenesis by analyzing PTEN mutation spectrum and the protein expression in breast cancers, adjacent hyperplastic lesions, benign breast lesions and normal breast tissues. Methods All 9 exons of PTEN gene were amplified by PCR with DNA extracted from 50 of human breast cancers and corresponding adjacent breast hyperplasia tissues, adjacent normal breast tissues, as well as 50 breast benign lesions residing in or around Yunnan, China, respectively. PCR products were then sequenced for mutation screening. And we also proved the effect of mutations on the expression of PTEN protein by immunohistochemistry. Results PTEN mutations were detected in 11 of 50 (22%) breast cancers and 4 of 50 (8%) adjacent ductal hyperplasia, all of which were atypical ductal hyperplasia and same PTEN mutation were detected in the corresponding cancer tissues. No PTEN mutation was detected in all adjacent normal breast tissues and 50 cases of breast benign lesions. The mutation sites concentrated at exon 3, 4, 5 and 7; no mutation was detected in exon 1, 2, 6, 8, or 9 and splicing sites of all introns. The hottest mutation spots were exon 5 with missense mutations. Immunohistochemical analysis showed that 24 of 50 (48%) breast cancers and 6 of 50 (12%) adjacent breast hyperplasia demonstrated negative immuno-staining of PTEN (loss of PTEN protein expression). All the 4 adjacent breast tissues harbored PTEN mutations and 9 of 11 breast cancers with PTEN mutation were loss of PTEN expression. Statistical analysis revealed that PTEN gene mutations were correlated with the PTEN expression. Conclusions The incidence of PTEN mutations is relatively high in patients with sporadic breast cancer in the region of Yunnan, China and exists at the early stage of breast cancer development. The PTEN mutations have significant effect on the expression silencing of PTEN protein indicating the important role of PTEN mutation in carcinogenesis of breast cancers.

Expression of PTEN Gene and Its Clinical Value in Canine Mammary Tumors

Expression and Significance of PTEN in Canine Mammary Gland Tumours

The Clinical Significance of PTEN Protein Expression in Colorectal Carcinoma

Relation between expressions of PTEN and VEGF and clinicopathological features in canine mammary gland tumors

Mutations of PTEN Gene in 117 Chinese Patients with Malignant Melanoma and Their Clinical Significance

Over-expression of PTEN on Proliferation and Apoptosis in Canine Mammary Tumors Cells

Expression of PTEN Protein and the Clinical Value of the Expression in Primary Breast Carcinoma

Quantification of VEGF-C Gene Expression in Canine Mammary Tumors by Real-Time Reverse Transcription Quantitative Polymerase Chain Reaction

Expression of PTEN Protein in Gastric Carcinoma, Adjacent Mucosa and Precancerous Lesions of Stomach and Its Significance

Clinical Value of the Expression of PTEN Gene,Progesterone Receptor and Estrogen Receptor for Predicting Biological Behaviors and Prognosis of Breast Carcinoma

PTEN mutation spectrum in breast cancers and breast hyperplasia

The Association of Expressions of PTEN Gene and Nm23 Gene with Biological Behaviors in Breast Cancer

Quantification of VEGF-C Expression in Canine Mammary Tumours.

The Analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF Expression in the Diagnosis of Canine Mammary Tumors.

Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor

Immunohistochemical Expression of PTEN in Canine Gliomas

Expression of PTEN and Its Significance in Breast Cancer

The expression and significance of PTEN in progression of colorectal cancer

Clinico-Pathological, Immunohistochemical and In-Situ TUNEL ASSAY Observations of Canine Breast Tumors

Histopathological observations of canine mammary gland tumors and expression analysis of tenascin-C

Evaluation Of Expression Of The Wnt Signaling Components In Canine Mammary Tumors Via Rt2 Profiler Pcr Array And Immunochemistry Assays